These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36349183)

  • 21. Polypoidal choroidal vasculopathy in a patient with DMPK-associated myotonic dystrophy.
    Iida Y; Hayashi T; Tokuhisa T; Mizobuchi K; Omoto S; Nakano T
    Doc Ophthalmol; 2022 Jun; 144(3):217-226. PubMed ID: 35284965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of gastrointestinal and urological symptoms in children with myotonic dystrophy type 1.
    Maagdenberg SJM; Klinkenberg S; Sophie van den Berg J; Altena-Rensen S; Vrijens D; Janssen EJM; Gierenz N; de Wall LL; Braakman HMH
    Neuromuscul Disord; 2024 Feb; 35():1-7. PubMed ID: 38184901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ dysfunction and muscular disability in myotonic dystrophy type 1.
    Kaminsky P; Poussel M; Pruna L; Deibener J; Chenuel B; Brembilla-Perrot B
    Medicine (Baltimore); 2011 Jul; 90(4):262-268. PubMed ID: 21694643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy.
    Vanacore N; Rastelli E; Antonini G; Bianchi ML; Botta A; Bucci E; Casali C; Costanzi-Porrini S; Giacanelli M; Gibellini M; Modoni A; Novelli G; Pennisi EM; Petrucci A; Piantadosi C; Silvestri G; Terracciano C; Massa R
    Neuroepidemiology; 2016; 46(3):191-7. PubMed ID: 26882032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and causes of death in adult-onset myotonic dystrophy.
    de Die-Smulders CE; Höweler CJ; Thijs C; Mirandolle JF; Anten HB; Smeets HJ; Chandler KE; Geraedts JP
    Brain; 1998 Aug; 121 ( Pt 8)():1557-63. PubMed ID: 9712016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myotonic dystrophy Curschmann-Steinert].
    Papageorgiou E; Bock SW; Schiefer U
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):70-5. PubMed ID: 17260325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cataract pateint with myotonic dystrophy.
    Van Dyk HJ; Swan KC
    Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(5):838-46. PubMed ID: 6066202
    [No Abstract]   [Full Text] [Related]  

  • 32. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
    Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
    Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eye disease with myotonic dystrophy type 1].
    Boonstra NE; Varhaug KN
    Tidsskr Nor Laegeforen; 2023 Sep; 143(13):. PubMed ID: 37753768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Having an eye for myotonic dystrophy: A qualitative study on experiences and support needs in myotonic dystrophy type 1 patients with a diagnostic delay after early-onset cataract.
    Karnebeek IEA; Boon HTM; Huis AMP; Cup EHC; Eggink CA; Schouten MI; van der Looij HJ; van Engelen BGM; Smulders FHP; Voermans NC
    Neuromuscul Disord; 2022 Oct; 32(10):829-835. PubMed ID: 36192279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of myotonic dystrophy type 1 in adults in western Sweden.
    Lindberg C; Bjerkne F
    Neuromuscul Disord; 2017 Feb; 27(2):159-162. PubMed ID: 28082207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.
    Klesert TR; Cho DH; Clark JI; Maylie J; Adelman J; Snider L; Yuen EC; Soriano P; Tapscott SJ
    Nat Genet; 2000 May; 25(1):105-9. PubMed ID: 10802667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine function in 97 patients with myotonic dystrophy type 1.
    Ørngreen MC; Arlien-Søborg P; Duno M; Hertz JM; Vissing J
    J Neurol; 2012 May; 259(5):912-20. PubMed ID: 22349862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.